<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Allergy: anaphylaxis; Shock: anaphylactic; Anaphylaxis; Anaphylactic shock; Arachis oil: presence of; Adrenaline: anaphylaxis; Oxygen: anaphylaxis; Antihistamines: allergic emergencies; Corticosteroids: allergic emergencies" /><meta name="IX" content="Allergy: anaphylaxis; Shock: anaphylactic; Anaphylaxis; Anaphylactic shock; Arachis oil: presence of; Adrenaline: anaphylaxis; Oxygen: anaphylaxis; Antihistamines: allergic emergencies; Corticosteroids: allergic emergencies" /><title>Anaphylaxis: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1970-anaphylaxis.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1970-anaphylaxis.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1970-anaphylaxis.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP1716-respiratory-system.htm">3 Respiratory system</a> &gt; <a href="PHP1895-antihistamines-hyposensitisation-and-allergic-emergencies.htm">3.4 Antihistamines, hyposensitisation, and allergic emergencies</a> &gt; <a href="PHP1969-allergic-emergencies.htm">3.4.3 Allergic emergencies</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1969-allergic-emergencies.htm" title="Previous: 3.4.3 Allergic emergencies">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1971-intramuscular-adrenaline-epinephrine.htm" title="Next: Intramuscular adrenaline (epinephrine)">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Anaphylaxis</h1><?highlighter on?><div id="pC" class="jN"><p>Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction. It is characterised by the rapid onset of respiratory and/or circulatory problems and is usually associated with skin and mucosal changes; prompt treatment is required. Patients with pre-existing asthma, especially poorly controlled asthma, are at particular risk of life-threatening reactions. Insect stings are a recognised risk (in particular wasp and bee stings). Latex and certain foods, including eggs, fish, cow's milk protein, peanuts, sesame, shellfish, soy, and tree nuts may also precipitate anaphylaxis. Medicinal products particularly associated with anaphylaxis include blood products, vaccines, hyposensitising (allergen) preparations, antibacterials, aspirin and other NSAIDs, and neuromuscular blocking drugs. In the case of drugs, anaphylaxis is more likely after parenteral administration; resuscitation facilities must always be available for injections associated with special risk. Anaphylactic reactions may also be associated with <em>additives and excipients</em> in foods and medicines. Refined arachis (peanut) oil, which may be present in some medicinal products, is unlikely to cause an allergic reaction—nevertheless it is wise to check the full formula of preparations which may contain allergens.</p><p><em>First-line treatment of anaphylaxis</em> includes securing the airway, restoration of blood pressure (laying the patient flat and raising the legs, or in the recovery position if unconscious or nauseated and at risk of vomiting) and administration of <strong>adrenaline</strong> (epinephrine) injection. Adrenaline is given <strong>intramuscularly </strong>in a dose of 500 micrograms (0.5 mL adrenaline injection 1 in 1000); a dose of 300 micrograms (0.3 mL adrenaline injection 1 in 1000) may be appropriate for <em>immediate self-administration</em>. The dose is repeated if necessary at 5-minute intervals according to blood pressure, pulse, and respiratory function (<strong>important:</strong> possible need for <em>intravenous route</em> using <em>dilute solution</em>, see <a title="BNF:monograph-subgroup: Intramuscular adrenaline (epinephrine)" href="PHP1971-intramuscular-adrenaline-epinephrine.htm">below</a>).  Patients receiving beta-blockers require special consideration (see under <a title="monograph: ADRENALINE/EPINEPHRINE" href="PHP1976-adrenalineepinephrine.htm">Adrenaline</a>). High-flow <strong>oxygen</strong> administration (<a title="BNF:section: Oxygen" href="PHP2009-oxygen.htm">section 3.6</a>) and intravenous fluids (<a title="sub-section: Parenteral preparations for fluid and electrolyte imbalance" href="PHP5994-parenteral-preparations-for-fluid-and-electrolyte-imbalance.htm">section 9.2.2</a>) are also of primary importance. An antihistamine (e.g. <strong>chlorphenamine</strong>, given by slow intravenous injection or intramuscular injection in a dose of 10 mg, see under <a title="monograph: CHLORPHENAMINE MALEATE/CHLORPHENIRAMINE MALEATE" href="PHP1934-chlorphenamine-maleate.htm">Chlorphenamine</a>) is a useful adjunctive treatment, given after adrenaline. An intravenous corticosteroid e.g. <strong>hydrocortisone</strong> (preferably as sodium succinate) in a dose of 200 mg (<a title=" Glucocorticoid therapy" href="PHP4331-glucocorticoid-therapy.htm">section 6.3.2</a>) is of secondary value in the initial management of anaphylaxis because the onset of action is delayed for several hours, but should be given to prevent further deterioration in severely affected patients.</p><p><em>Continuing respiratory deterioration</em> requires further treatment with <strong>bronchodilators</strong> including inhaled or intravenous salbutamol (see under <a title="monograph: SALBUTAMOL" href="PHP1756-salbutamol.htm">Salbutamol</a>), inhaled ipratropium (see under <a title="monograph: IPRATROPIUM BROMIDE" href="PHP1791-ipratropium-bromide.htm">Ipratropium</a>), intravenous aminophylline (see under <a title="monograph: AMINOPHYLLINE" href="PHP1811-aminophylline.htm">Aminophylline</a>), or intravenous magnesium sulfate [unlicensed indication] (see <a title="sub-topic: Acute severe asthma" href="PHP1722-management-of-severe-acute-asthma.htm">Acute Severe Asthma</a>); in addition to oxygen, assisted respiration and possibly emergency tracheotomy may be necessary. </p><p>When a patient is so ill that there is doubt about the adequacy of the circulation, the initial injection of adrenaline may need to be given as a <em>dilute solution by the intravenous route</em>; for details of cautions, dose, and strength, see under <a title="BNF:monograph-subgroup: Intravenous adrenaline (epinephrine)" href="PHP1973-intravenous-adrenaline-epinephrine.htm">Intravenous Adrenaline (Epinephrine)</a>.</p><p>Cardiopulmonary arrest may follow an anaphylactic reaction; resuscitation should be started immediately (see <a title="sub-section: Cardiopulmonary resuscitation" href="PHP1434-cardiopulmonary-resuscitation.htm">Cardiopulmonary Resuscitation</a>).</p><p>For advice on the management of medical emergencies in dental practice, see <a title="sub-topic: Anaphylaxis" href="PHP147-anaphylaxis.htm">Prescribing in Dental Practice</a>.</p><p>On discharge, patients should be considered for further treatment with an oral antihistamine (<a title="BNF:sub-section: Antihistamines" href="PHP1896-antihistamines.htm">section 3.4.1</a>) and an oral corticosteroid (<a title="BNF:sub-section: Glucocorticoid therapy" href="PHP4331-glucocorticoid-therapy.htm">section 6.3.2</a>) for up to 3 days to reduce the risk of further reaction. Patients should be instructed to return to hospital if symptoms recur and to contact their general practitioner for follow-up.</p><p>Patients who are suspected of having had an anaphylactic reaction should be referred to a specialist for specific allergy diagnosis. Avoidance of the allergen is the principal treatment; if appropriate, an adrenaline auto-injector should be given or a replacement supplied (see <a title="BNF:monograph-subgroup: Self-administration of adrenaline (epinephrine)" href="PHP1975-self-administration-of-adrenaline-epinephrine.htm">Self-administration of Adrenaline</a>).</p></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP1971-intramuscular-adrenaline-epinephrine.htm" title="Intramuscular adrenaline (epinephrine)">Intramuscular adrenaline (epinephrine)</a></li><li><a href="PHP1973-intravenous-adrenaline-epinephrine.htm" title="Intravenous adrenaline (epinephrine)">Intravenous adrenaline (epinephrine)</a></li><li><a href="PHP1975-self-administration-of-adrenaline-epinephrine.htm" title="Self-administration of adrenaline (epinephrine)">Self-administration of adrenaline (epinephrine)</a></li><li id="_PHP1976-adrenalineepinephrine"><a href="PHP1976-adrenalineepinephrine.htm" title="ADRENALINE/EPINEPHRINE">ADRENALINE/EPINEPHRINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1969-allergic-emergencies.htm">Previous: 3.4.3 Allergic emergencies</a> | <a class="top" href="PHP1970-anaphylaxis.htm#">Top</a> | <a accesskey="]" href="PHP1971-intramuscular-adrenaline-epinephrine.htm">Next: Intramuscular adrenaline (epinephrine)</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>